Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2006

01-03-2006 | Letter to the Editor

Unusual relapse of acute myeloid leukemia: granulocytic sarcoma presenting as an acute paraplegia

Authors: Hee Yun Seo, Seok Jin Kim, Jung Woo Choi, Jang Bo Lee, Chang Ho Kang, Bo Kyoung Seo, Byung Soo Kim

Published in: Annals of Hematology | Issue 3/2006

Login to get access

Excerpt

Dear Editor …
Literature
1.
Landis DM, Aboulafia DM (2003) Granulocytic sarcoma: an unusual complication of aleukemic myeloid leukemia causing spinal cord compression. A case report and literature review. Leuk Lymphoma 44:1753–1760PubMedCrossRef
2.
Krause JR (1979) Granulocytic sarcoma preceding acute leukemia: a report of six cases. Cancer 44:1017–1021PubMedCrossRef
3.
Nguyen S, Leblanc T, Fenaux P, Witz F, Blaise D, Pigneux A et al (2002) A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup. Blood 99:3517–3523PubMedCrossRef
4.
Roth MJ, Medeiros LJ, Elenitoba-Johnson K, Kuchnio M, Jaffe ES, Stetler-Stevenson M (1995) Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections. Arch Pathol Lab Med 119:790–798PubMed
5.
Krishnan K, Ross CW, Adams PT, Pereira A, Roth MS (1994) Neural cell-adhesion molecule (CD 56)-positive, t(8;21) acute myeloid leukemia (AML, M-2) and granulocytic sarcoma. Ann Hematol 69:321–323PubMedCrossRef
Metadata
Title
Unusual relapse of acute myeloid leukemia: granulocytic sarcoma presenting as an acute paraplegia
Authors
Hee Yun Seo
Seok Jin Kim
Jung Woo Choi
Jang Bo Lee
Chang Ho Kang
Bo Kyoung Seo
Byung Soo Kim
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 3/2006
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-005-0056-2

Other articles of this Issue 3/2006

Annals of Hematology 3/2006 Go to the issue

Review Article

Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias

Letter to the Editor

Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease

Letter to the Editor

Lymphoma presenting as chronic aortic dissection in Marfan syndrome

Letter to the Editor

Successful treatment of lymph node extramedullary plasmacytoma with bortezomib

Letter to the Editor

Cutaneous zygomycosis at catheter insertion site in AML-M4Eo

Letter to the Editor

Is splenectomy a contraindication for patients with myelodysplastic syndromes complicated by splenomegaly?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits